168 related articles for article (PubMed ID: 22718454)
1. [Central venous catheter lock to prevent thrombosis and bacterial infection].
Mandolfo S
G Ital Nefrol; 2012; 29(3):301-7. PubMed ID: 22718454
[TBL] [Abstract][Full Text] [Related]
2. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
Yon CK; Low CL
Am J Health Syst Pharm; 2013 Jan; 70(2):131-6. PubMed ID: 23292266
[TBL] [Abstract][Full Text] [Related]
3. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients.
Moore CL; Besarab A; Ajluni M; Soi V; Peterson EL; Johnson LE; Zervos MJ; Adams E; Yee J
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1232-9. PubMed ID: 24970874
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of 30 % trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial).
Correa Barcellos F; Pereira Nunes B; Jorge Valle L; Lopes T; Orlando B; Scherer C; Nunes M; Araújo Duarte G; Böhlke M
Infection; 2017 Apr; 45(2):139-145. PubMed ID: 27573387
[TBL] [Abstract][Full Text] [Related]
6. An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study.
Vercaigne LM; Allan DR; Armstrong SW; Zacharias JM; Miller LM
J Vasc Access; 2016; 17(1):55-62. PubMed ID: 26660041
[TBL] [Abstract][Full Text] [Related]
7. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
[TBL] [Abstract][Full Text] [Related]
8. Effect of ultra-low dose and standard heparin locks on early tunnelled dialysis catheter outcomes in low-risk dialysis patients.
Renaud CJ; Lim EK; Tho SJ; Yeoh LY
Nephrology (Carlton); 2015 Feb; 20(2):85-90. PubMed ID: 25346031
[TBL] [Abstract][Full Text] [Related]
9. Pros and cons of catheter lock solutions.
Niyyar VD; Lok CE
Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):669-74. PubMed ID: 24100219
[TBL] [Abstract][Full Text] [Related]
10. Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review.
Wang Y; Sun X
Ren Fail; 2022 Dec; 44(1):1501-1518. PubMed ID: 36047812
[TBL] [Abstract][Full Text] [Related]
11. [Management of central venous catheter: prevention of thrombosis and bacteremia].
Lomonte C; Basile C
G Ital Nefrol; 2009; 26(1):73-80. PubMed ID: 19255966
[TBL] [Abstract][Full Text] [Related]
12. Citrate versus heparin lock for prevention of hemodialysis catheter-related complications: updated systematic review and meta-analysis of randomized controlled trials.
Mai H; Zhao Y; Salerno S; Li Y; Feng Y; Ma L; Fu P
Int Urol Nephrol; 2019 Jun; 51(6):1019-1033. PubMed ID: 31012037
[TBL] [Abstract][Full Text] [Related]
13. Catheter dysfunction: the role of lock solutions.
Niyyar VD
Semin Dial; 2012; 25(6):693-9. PubMed ID: 22175421
[TBL] [Abstract][Full Text] [Related]
14. Locking tunneled hemodialysis catheters with hypertonic saline (26% NaCl) and heparin to prevent catheter-related bloodstream infections and thrombosis: a randomized, prospective trial.
Oguzhan N; Pala C; Sipahioglu MH; Cilan H; Durmaz S; Percin D; Unal A; Tokgoz B; Utas C; Oymak O
Ren Fail; 2012; 34(2):181-8. PubMed ID: 22260745
[TBL] [Abstract][Full Text] [Related]
15. Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial.
Souweine B; Lautrette A; Gruson D; Canet E; Klouche K; Argaud L; Bohe J; Garrouste-Orgeas M; Mariat C; Vincent F; Cayot S; Cointault O; Lepape A; Guelon D; Darmon M; Vesin A; Caillot N; Schwebel C; Boyer A; Azoulay E; Bouadma L; Timsit JF
Am J Respir Crit Care Med; 2015 May; 191(9):1024-32. PubMed ID: 25668557
[TBL] [Abstract][Full Text] [Related]
16. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis.
Han X; Yang X; Huang B; Yuan L; Cao Y
Clin Nephrol; 2016 Jul; 86(7):1-8. PubMed ID: 27191662
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus.
Pittiruti M; Bertoglio S; Scoppettuolo G; Biffi R; Lamperti M; Dal Molin A; Panocchia N; Petrosillo N; Venditti M; Rigo C; DeLutio E
J Vasc Access; 2016 Nov; 17(6):453-464. PubMed ID: 27516141
[TBL] [Abstract][Full Text] [Related]
19. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
Quarello F; Forneris G; Borca M; Pozzato M
J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
[TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access.
Bleyer AJ; Mason L; Russell G; Raad II; Sherertz RJ
Infect Control Hosp Epidemiol; 2005 Jun; 26(6):520-4. PubMed ID: 16018426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
